Valuation Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 16:00:00 2026-05-21 EDT			5-day change	1st Jan Change
115.87 ^USD	+2.54%		+2.17%	+10.08%

05-20	National Advertising Review Board refers Merck animal health to FTC & FDA for Bravecto Quantum dosing claims	RE
05-20	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	193,588	281,302	276,259	251,648	261,258	279,090	-	-
Change	-	45.31%	-1.79%	-8.91%	3.82%	6.83%	-	-
Enterprise Value (EV) ¹	218,594	298,801	304,221	275,517	296,032	315,470	303,012	286,023
Change	-	36.69%	1.81%	-9.44%	7.45%	6.57%	-3.95%	-5.61%
P/E ratio	14.9x	19.4x	779x	14.8x	14.5x	50.4x	13.6x	11.8x
PBR	5.07x	6.12x	7.34x	5.44x	5.01x	5.74x	4.76x	3.91x
PEG	-	1.7x	-8x	0x	1.81x	-0.7x	0x	0.8x
Capitalization / Revenue	3.97x	4.75x	4.6x	3.92x	4.02x	4.17x	3.97x	3.69x
EV / Revenue	4.49x	5.04x	5.06x	4.29x	4.55x	4.72x	4.31x	3.78x
EV / EBITDA	10.5x	11.3x	30.2x	9.88x	9.08x	19.2x	8.96x	7.86x
EV / EBIT	12.4x	13.3x	49x	11.8x	11.1x	26.7x	10.6x	9.01x
EV / FCF	25.2x	20.3x	33.3x	15.2x	24x	26.9x	13.3x	11.4x
FCF Yield	3.97%	4.92%	3.01%	6.57%	4.18%	3.71%	7.53%	8.77%
Dividend per Share ²	2.64	2.8	2.96	3.12	3.28	3.344	3.463	3.674
Rate of return	3.44%	2.52%	2.72%	3.14%	3.12%	2.96%	3.06%	3.25%
EPS ²	5.14	5.71	0.14	6.74	7.28	2.241	8.312	9.604
Distribution rate	51.4%	49%	2,114%	46.3%	45.1%	149%	41.7%	38.3%
Net sales ¹	48,704	59,283	60,115	64,168	65,011	66,848	70,305	75,734
EBITDA ¹	20,910	26,431	10,083	27,897	32,617	16,449	33,831	36,383
EBIT ¹	17,696	22,522	6,211	23,398	26,779	11,837	28,667	31,758
Net income ¹	13,049	14,519	365	17,117	18,254	5,556	20,425	23,378
Net Debt ¹	25,006	17,499	27,962	23,869	34,774	36,379	23,922	6,933
Reference price ²	76.64	110.95	109.02	99.48	105.26	113.00	113.00	113.00
Nbr of stocks (in thousands)	2,525,944	2,535,396	2,534,023	2,529,636	2,482,023	2,469,824	-	-
Announcement Date	2/3/22	2/2/23	2/1/24	2/4/25	2/3/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
MERCK & CO., INC.	50.41x	4.72x	19.18x	2.96%	279B
ELI LILLY AND COMPANY	29.89x	10.84x	22.39x	0.67%	909B
JOHNSON & JOHNSON	24.51x	5.65x	15.38x	2.33%	552B
ABBVIE INC.	25.84x	6.38x	13.02x	3.23%	375B
ROCHE HOLDING AG	17.34x	4.33x	10.67x	3.06%	332B
ASTRAZENECA PLC	23.61x	4.9x	13.82x	1.78%	291B
NOVARTIS AG	20.91x	5.6x	13.61x	3.02%	287B
NOVO NORDISK A/S	13.06x	4.8x	9.79x	3.86%	199B
AMGEN INC.	21.56x	5.83x	10.18x	3.04%	179B
GILEAD SCIENCES, INC.	-47.41x	5.64x	31.74x	2.48%	162B
Average	17.97x	5.87x	15.98x	2.64%	356.53B
Weighted average by Cap.	22.96x	6.75x	16.68x	2.26%